MX2018000395A - Proteinas y composiciones inmunizantes que contienen proteinas de klebsiella y metodos de uso. - Google Patents

Proteinas y composiciones inmunizantes que contienen proteinas de klebsiella y metodos de uso.

Info

Publication number
MX2018000395A
MX2018000395A MX2018000395A MX2018000395A MX2018000395A MX 2018000395 A MX2018000395 A MX 2018000395A MX 2018000395 A MX2018000395 A MX 2018000395A MX 2018000395 A MX2018000395 A MX 2018000395A MX 2018000395 A MX2018000395 A MX 2018000395A
Authority
MX
Mexico
Prior art keywords
proteins
methods
compositions containing
immunizing compositions
containing klebsiella
Prior art date
Application number
MX2018000395A
Other languages
English (en)
Spanish (es)
Inventor
T Burkhardt Douglas
Emery Daryll
STRAUB Darren
Original Assignee
Epitopix Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epitopix Llc filed Critical Epitopix Llc
Publication of MX2018000395A publication Critical patent/MX2018000395A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0266—Klebsiella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/116—Polyvalent bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/26—Klebsiella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2018000395A 2015-07-10 2016-07-08 Proteinas y composiciones inmunizantes que contienen proteinas de klebsiella y metodos de uso. MX2018000395A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562190947P 2015-07-10 2015-07-10
PCT/US2016/041614 WO2017011340A2 (en) 2015-07-10 2016-07-08 Proteins and immunizing compositions containing klebsiella proteins and methods of use

Publications (1)

Publication Number Publication Date
MX2018000395A true MX2018000395A (es) 2018-05-23

Family

ID=56555778

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018000395A MX2018000395A (es) 2015-07-10 2016-07-08 Proteinas y composiciones inmunizantes que contienen proteinas de klebsiella y metodos de uso.

Country Status (7)

Country Link
US (3) US11000582B2 (enExample)
EP (1) EP3319628A2 (enExample)
JP (2) JP7222711B2 (enExample)
CN (1) CN107921114A (enExample)
CA (1) CA2991907A1 (enExample)
MX (1) MX2018000395A (enExample)
WO (1) WO2017011340A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002053180A2 (en) * 2001-01-03 2002-07-11 Willmar Poultry Company, Inc. Immunizing compositions and methods of use
CA2991907A1 (en) * 2015-07-10 2017-01-19 Douglas T. Burkhardt Proteins and immunizing compositions containing klebsiella proteins and methods of use
US10166280B2 (en) 2016-06-08 2019-01-01 Epitopix, Llc Polypeptides and immunizing compositions containing Bacillus polypeptides and methods of use
ES2945137T3 (es) 2017-02-10 2023-06-28 Epitopix Llc Proteínas y composiciones inmunitarias que contienen proteínas de Pasteurella y métodos de uso
CA3138237A1 (en) * 2019-04-26 2020-10-29 Cornell University Klebsiella vaccine and methods of use
CN111647057B (zh) * 2020-05-07 2022-09-13 西南医科大学附属中医医院 一种伤寒沙门菌疫苗重组蛋白及其编码基因和它们的应用
EP4422677A1 (en) * 2021-10-29 2024-09-04 Vaxxinova US, Inc. Methods and compositions for preventing infection
CN115975890A (zh) * 2023-02-02 2023-04-18 深圳元健生命科技有限公司 一种产气克雷伯氏菌及其应用
CN115798574B (zh) * 2023-02-06 2023-06-02 中国医学科学院北京协和医院 一种预测克雷伯氏菌属对美罗培南敏感性的系统及方法
CN119679930B (zh) * 2025-02-24 2025-07-25 吉林大学第一医院 一种肺炎克雷伯菌表面膜蛋白的应用和疫苗
CN120330106B (zh) * 2025-06-05 2025-08-26 云南省农业科学院茶叶研究所 一种产酸克雷伯氏菌株及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2644346B1 (fr) * 1989-03-20 1994-05-13 Rhone Merieux Vaccins contre les bacteries septicemiques, preparations d'antigenes de bacteries septicemiques, nouvelles bacteries et vecteurs pour la preparation de ces antigenes ou vaccins
CA2182976C (en) 1994-02-09 2011-07-12 Daryll A. Emery Active immunization using a siderophore receptor protein
US5538733A (en) 1994-07-07 1996-07-23 Willmar Poultry Company, Inc. Method of priming an immune response in a one-day old animal
US6610836B1 (en) 1999-01-29 2003-08-26 Genome Therapeutics Corporation Nucleic acid amino acid sequences relating to Klebsiella pneumoniae for diagnostics and therapeutics
US6682754B2 (en) 1999-11-24 2004-01-27 Willmar Poultry Company, Inc. Ovo delivery of an immunogen containing implant
WO2002053180A2 (en) 2001-01-03 2002-07-11 Willmar Poultry Company, Inc. Immunizing compositions and methods of use
BRPI0414267A (pt) 2003-09-19 2006-11-21 Epitopix Llc polipeptìdeos de campilobacter e métodos de uso
BRPI0607323B8 (pt) 2005-02-14 2021-05-25 Epitopix Llc composições, usos de polipeptídeos e de anticorpos, bem como kits para a detecção de anticorpo que se liga especificamente a um polipeptídeo
EP2152731A2 (en) * 2007-05-02 2010-02-17 Intercell AG Klebsiella antigens
BRPI1011856A2 (pt) * 2009-03-23 2020-11-03 Epitopix, Llc polipeptídeos e composições de imunização contendo polipeptídeos gram-positivos e métodos de uso
US9073990B2 (en) * 2010-04-05 2015-07-07 Bar-Llan University Protease-activatable pore-forming polypeptides
CA2991907A1 (en) * 2015-07-10 2017-01-19 Douglas T. Burkhardt Proteins and immunizing compositions containing klebsiella proteins and methods of use

Also Published As

Publication number Publication date
WO2017011340A2 (en) 2017-01-19
CN107921114A (zh) 2018-04-17
US20210330776A1 (en) 2021-10-28
US20240216494A1 (en) 2024-07-04
EP3319628A2 (en) 2018-05-16
US20190070281A1 (en) 2019-03-07
WO2017011340A3 (en) 2017-04-13
CA2991907A1 (en) 2017-01-19
US11872273B2 (en) 2024-01-16
US11000582B2 (en) 2021-05-11
JP7222711B2 (ja) 2023-02-15
JP2021063084A (ja) 2021-04-22
JP2018527405A (ja) 2018-09-20

Similar Documents

Publication Publication Date Title
ZA202107931B (en) Anti-tau antibodies and methods of use
MX2018000395A (es) Proteinas y composiciones inmunizantes que contienen proteinas de klebsiella y metodos de uso.
MX2019007020A (es) Anticuerpos il-11.
MX2019007021A (es) Anticuerpos il-11ra.
PH12017500861A1 (en) Anti-interleukin-33 antibodies and uses thereof
HUE062446T2 (hu) Vegyületek, készítmények és eljárások
MY191581A (en) Anti-pd-1 antibodies
EP4279071A3 (en) Novel cannabinoid formulations
MX2020003760A (es) Formulaciones de niraparib.
MX2020005213A (es) Inhibidores de proteina cinasa 2 activada por proteina cinasa activada por mitogeno (mk2) y sus usos.
MX2017003478A (es) Anticuerpos anti-fgfr2/3 y metodos para su uso.
SG10201803042PA (en) Anti-tim-3 antibodies
MY192927A (en) Fused bicyclic compounds for the treatment of disease
MX2017016169A (es) Anticuerpos anti-her2 y metodos de uso.
MX2016015162A (es) Anticuerpos anti - gpc3 e inmunoconjugados.
MY176855A (en) Anti-jagged1 antibodies and methods of use
MX369623B (es) Compuestos biciclicos fusionados para el tratamiento de enfermedades.
MX2020012893A (es) Formulaciones de proteinas.
SG11201609677WA (en) Method for reducing the chlorine content of organomonophosphites using dimethylaminobutane, triethylamine or triethanolamine
MX2017008390A (es) Uretanos funcionalizados con alcoxisilano y funcionalizados con alofanato.
MX2017010883A (es) Composicion para el tratamiento de la infertilidad.
MX2017000527A (es) Formulaciones de anticuerpos cristalinos.
GB2576614B (en) Compositions, uses and methods
IL270505B1 (en) Compounds, preparations and methods
MX2021006003A (es) Formulaciones de anticuerpos cristalinos.